首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到20条相似文献,搜索用时 31 毫秒
1.

Purpose

Real-time image guidance and navigation have become increasingly important in an era of minimally invasive interventional and surgical procedures in the liver. To develop, test, and implement tools for real-time image guidance, the authors sought to create an in vivo tumor mimic with realistic imaging and treatment capabilities.

Materials and Methods

Hepatic pseudotumors were created by injecting 1–2 mL of alginate (a hydrocolloid) directly into the liver parenchyma in eight live pigs and two dog cadavers. Tumors were imaged by B-mode ultrasound (US), US elasticity imaging, multi–detector row computed tomography (CT), CT fluoroscopy, and magnetic resonance (MR) imaging to assess imaging capabilities. Procedures performed with the alginate pseudotumors included radiofrequency (RF) ablation and robotic needle guidance.

Results

Twenty-four hepatic pseudotumors were created, ranging in size from 10 mm to 28 mm at an average depth of 6 mm. Average time of preparation and insertion was 3 minutes. All tumors were palpable under the surface of the liver and were easily visible on B-mode US, US elasticity imaging, CT, and MR imaging. Tumors were successfully “treated” with RF ablation, and gross examination of the liver showed good encompassment of the tumor by the zone of thermal coagulation. In addition, the pseudotumors allowed for easy introduction of various types of needles, including RF ablation probes and experimental steerable needles.

Conclusions

Alginate pseudotumors can easily be imaged and allow for different procedures to be performed. This model can be used for various research purposes.  相似文献   

2.

Purpose

To describe an in vitro blood-perfused bovine liver model for the testing of radiofrequency (RF) ablation devices and compare the performance of a specific RF ablation device in the model relative to three other biologic models.

Materials and Methods

Fresh bovine livers were used to create three in vitro models: blood-perfused, Krebs–Henseleit (KH) solution–perfused, and nonperfused. The perfused models were connected to a heart–lung machine via the portal vein and perfused with heparinized autologous blood or KH solution under physiologic conditions. Six swine were used as in vivo liver models. A cluster electrode and RF ablation system was operated in impedance mode for 12 minutes in all models. Ablated livers were sectioned, with long- and short-axis measurements of the ablations obtained, and statistical analysis was performed.

Results

A total of 39, 23, 17, and 12 ablations were performed in 14, 6, 5, and 6 blood-perfused bovine livers, KH solution–perfused bovine livers, nonperfused bovine livers, and in vivo porcine livers, respectively. On cut specimens, the average diameters of ablation zones were 4.00 cm (95% CI, 3.88–4.13) in blood-perfused livers, 4.34 cm (95% CI, 4.14–4.50) in KH solution–perfused livers, 4.67 cm (95% CI, 4.50–4.83) in nonperfused livers, and 3.56 cm (95% CI, 3.26–3.83) in in vivo porcine livers. In all models, the ablation zone diameters were normally distributed.

Conclusions

In the in vitro blood-perfused bovine liver model, the size of ablations produced by an RF ablation device are closer in size to those seen in porcine liver in vivo compared with the lesions produced in KH solution–perfused or nonperfused bovine liver.  相似文献   

3.

Objectives

The purpose of the study was to retrospectively compare technique effectiveness of computed tomography (CT)-guided versus magnetic resonance (MR)-guided radiofrequency (RF) ablation of hepatocellular carcinoma (HCC).

Materials and methods

In 35 consecutive patients 53 CT-guided (n = 29) or MR-guided (n = 24) ablation procedures were performed in the treatment of 56 (CT: 29; MR: 27) HCC. The entire ablation procedure was performed at a multislice CT-scanner or an interventional 0.2-Tesla MR-scanner. Assessment of treatment response was based on dynamic MR imaging at 1.5 Tesla. The mean follow-up was 22.9 months. Primary technique effectiveness was assessed 4 months after ablation therapy. Secondary technique effectiveness was assessed 4 months after a facultative second ablation procedure. Primary and secondary technique effectiveness of CT-guided and MR-guided RF ablation was compared by using Chi-Square (likelihood ratio) test.

Results

Primary technique effectiveness after a single session was achieved in 26/27 (96.3%) HCC after MR-guided RF ablation and 23/29 (79.3%) HCC after CT-guided RF ablation (Chi-Square: p = 0.04). Secondary technique effectiveness was achieved in 26/27 (96.3%) HCC after MR-guided RF ablation and in 26/29 (89.7%) HCC after CT-guided RF ablation (Chi-Square: p = 0.32). A local tumor progression was detected in 8/52 (15.4%) tumors after initial technique effectiveness. Major complications were detected after 3/53 (5.7%) ablation procedures.

Conclusions

CT-guided and MR-guided RF ablations are locally effective therapies in the treatment of HCC. Due to a higher rate of primary technique effectiveness MR-guided RF ablation may reduce the number of required sessions for complete tumor treatment.  相似文献   

4.

Purpose

To evaluate the ability of multidetector row computed tomography (CT) to detect blood supply from the intercostal artery in patients with hepatocellular carcinoma (HCC).

Materials and Methods

Between January 2003 and December 2007, angiography of the intercostal artery was performed in 93 patients (76 men and 17 women, mean age 58 years) with HCC who had also undergone multidetector row CT. CT scans and digital subtraction angiograms of these patients were retrospectively reviewed by two investigators in consensus to evaluate tumor feeding vessels. Multiple logistic regression analysis was used to identify factors that predict the presence of an HCC blood supply from an intercostal artery.

Results

Tumor staining fed by an intercostal artery was noted in 65 patients (70%; 112 tumor feeding vessels) by intercostal angiography. Readers interpreted that tumor feeding vessels were evident by CT in 35 (54%) of these 65 patients with tumor staining supplied by an intercostal artery by angiography. Multiple logistic regression analysis showed that a visible tumor feeding vessel by CT (P = .003) and hepatic artery attenuation by angiography (P = .014) were significantly related to the presence of a blood supply from an intercostal artery.

Conclusions

Visualization of a tumor feeding vessel from the intercostal artery by multidetector row CT is an important sign of parasitic supply to an HCC.  相似文献   

5.

Purpose

To compare liver resection (LR) with single-step, balloon-occluded radiofrequency (RF) ablation plus drug-eluting embolics transarterial chemoembolization in cirrhotic patients with single hepatocellular carcinoma (HCC) ≥ 3 cm.

Materials and Methods

From 2010 to 2014, 25 patients with compensated cirrhosis and single HCC ≥ 3 cm (median size 4.5 cm; range, 3.0–6.8 cm) not suitable for LR or liver transplantation were treated with RF ablation plus transarterial chemoembolization in a prospective observational single-center pilot study; all patients had complete tumor necrosis after treatment. A retrospective control group included 29 patients (median HCC size 4.0 cm; range, 3.0–7.4 cm) who underwent LR. RF ablation plus transarterial chemoembolization group included more patients with severe portal hypertension (65.5% vs 35.0%, P = .017). Primary endpoints were overall survival (OS) and tumor recurrence (TR) rates.

Results

One death and 1 major complication (4%) were observed in LR group. No major complications were reported in RF ablation plus transarterial chemoembolization group (P = .463). OS rates at 1 and 3 years were 91.8% and 79.3% in LR group and 89.4% and 48.2% in RF ablation plus transarterial chemoembolization group (P = 0.117). TR rates at 1 and 3 years were 29.5% and 45.0% in LR group and 42.4% and 76.0% in RF ablation plus transarterial chemoembolization group (P = .034). Local tumor progression (LTP) rates at 3 years were significantly lower in LR group (21.8% vs 58.1%, P = .005). Similar results were found in patients with HCC ≤ 5 cm (TR rates 35.4% vs 75.1%, P = .016; LTP 16.0% vs 55.7%, P = .013).

Conclusions

LR achieved lower TR and LTP rates than RF ablation plus transarterial chemoembolization, but 3-years OS rates were not statistically different between the 2 groups. RF ablation plus transarterial chemoembolization is an effective treatment option in patients with compensated cirrhosis and solitary HCC ≥ 3 cm unsuitable for LR.  相似文献   

6.

Objective

To determine the ability of MR imaging to detect the pathological changes occurring in radiofrequency (RF) thermal lesions and to assess its accuracy in revealing the extent of tissue necrosis.

Materials and Methods

Using an RF electrode, thermal lesions were created in the livers of 18 rabbits. The procedure involved three phases. In the acute phase, six animals were killed the day after performing thermal ablation with RF energy, and two on day 3. In the subacute and chronic phases, eight rabbits underwent percutaneous hepatic RF ablation. After performing MR imaging, two animals were sacrificed at 1, 2, 4, and 7 weeks after the procedure, and MR-pathologic correlation was performed.

Results

In the acute phase, the thermal ablation lesions appeared at gross examination as well-circumscribed, necrotic areas, representing early change in the coagulative necrosis seen at microscopic examination. They were hypointense on T2-weighted images, and hyperintense on T1-weighted images. Gadolinium-enhanced MR imaging showed that a thin hyperemic rim surrounded the central coagulative necrosis. In the subacute phase, ablated lesions also showed extensive coagulative necrosis and marked inflammation at microscopic examination. Beyond two weeks, the lesions showed gradual resorption of the necrotic area, with a peripheral fibrovascular rim. The size of lesions measured by MR imaging correlated well with the findings at gross pathologic examination.

Conclusion

MR imaging effectively demonstrates the histopathological tissue change occurring after thermal ablation, and accurately determines the extent of the target area.  相似文献   

7.

Objective

To investigate the therapeutic response of radiofrequency ablation for treatment of hepatocellular carcinoma and the consequence of portal hypertension on the survival final results.

Patients & methods

168 patients with portal hypertension undergo radiofrequency ablation in the act of treatment of HCC (≤5?cm). Therapeutic response and prognostic outcomes were then analyzed. Overall survival was assessed using Kaplan-Meier method and multivariate analysis was achieved using the Cox regression model.

Results

Primary and secondary complete ablation of HCC was obtained in 86.3% & 100% of patients respectively. Complication occurred in 13.6% of patients, and thrombocytopenia and prolonged prothrombin time were independent risk factors of complication. Overall survival after the follow-up period of about 25?months was 74.4%. Two elements based on multivariate analysis had been recognized as prognostic factors for poor survival: Thrombocytopenia (HR?=?1.008, P?=?.004), and left lobe location of the tumor (HR?=?0.392, P?≤?.03).

Conclusion

This current study has shown that most cirrhotic patients with portal hypertension can tolerate RF ablation of HCC. The improved patient selection in terms of simple parameters such as platelet count, and prothrombin concentration, we will improve the outcome of RF ablation.  相似文献   

8.

Objective

To evaluate the technical effectiveness, technical success and patient safety of MR-guided radiofrequency (RF) ablation of liver malignancies using a wide-bore 1.5-T MR system.

Methods

In 110 patients, 56 primary liver lesions and 157 liver metastases were treated in 157 sessions using percutaneous RF ablation. Mean lesion diameter was 20?mm (range 4–54?mm). All planning, procedural and post-interventional control MR investigations were carried out using a wide-bore 1.5-T MR system. Technical success was assessed by a contrast-enhanced MR liver examination immediately after the intervention. Technique effectiveness was assessed by dynamic hepatic MR study 1?month post ablation; mean follow-up period was 24.2?months (range 5–44).

Results

Technical success and technique effectiveness were achieved in 210/213 lesions (98.6?%). In 18/210 lesions (8.6?%), local tumour progression occurred 4–28?months after therapy. Seven of these 18 lesions were treated in a second session achieving complete ablation, 6 other lesions were referred to surgery. Overall RF effectiveness rate was 199/213 (93.4?%); overall therapy success (including surgery) was 205/213 (96.2?%). Two major complications (1.3?%) (bleeding and infected biloma) and 14 (8.9?%) minor complications occurred subsequent to 157 interventions.

Conclusion

Wide-bore MR-guided RF ablation is a safe and effective treatment option for liver lesions.

Key Points

? Magnetic resonance-guided radiofrequency ablation offers various options for monitoring therapy. ? All steps of RF ablation carried out in 1.5-T wide-bore system. ? Therapeutic decisions were based on T1-weighted imaging. ? Technical success and technical effectiveness were high. ? Local tumour progression rate was 8.6?% over a 24-month mean follow-up.  相似文献   

9.

Purpose

To compare survival outcomes of small solitary hepatocellular carcinomas (HCCs) treated with thermal ablation vs resection in the Surveillance, Epidemiology, and End Results (SEER) cohort.

Materials and Methods

SEER data (November 2014 submission) were searched for histologic diagnoses of HCC and stage T1 disease (≤ 5-cm solitary tumor without vascular invasion). Comparison was made between thermal ablation and resection as the primary treatment. Overall and disease-specific survival were compared by log-rank tests (stratified for presence of fibrosis) and Cox regression (with tumor size and presence of fibrosis covariates).

Results

Of 264 patients with ≤ 2-cm HCCs, 185 underwent thermal ablation and 79 underwent resection. Patients undergoing ablation had higher Ishak scores (P = .0002). There was no difference in survival (observed P = .698, disease-specific P = .446). Of 544 patients with 2.1–4-cm HCCs, 335 underwent thermal ablation and 209 underwent resection. Patients undergoing ablation were more likely to have higher Ishak scores (P < .001), but had slightly smaller tumors (2.9 vs 3.1 cm; P < .001). There was no difference in survival (observed P = .174, disease-specific P = .609). Of 112 patients with 4.1–5-cm HCCs, 46 underwent thermal ablation and 66 underwent resection. Patients undergoing ablation had higher Ishak scores (P = .0002). Surgical resection was associated with improved survival (observed P = .009, disease-specific P = .046).

Conclusions

There was no difference in overall or disease-specific survival between surgical resection and thermal ablation for T1 HCCs ≤ 4 cm after adjusting for the presence of histologic fibrosis and tumor size in the SEER cohort. Significant benefit was observed with surgery for tumors measuring 4.1–5 cm.  相似文献   

10.

Objective

This study aimed to determine whether background enhancement on MR was related to mammographic breast density or ultrasonographic background echotexture in premenopausal and postmenopausal women.

Materials and methods

We studied 142 patients (79 premenopausal, 63 postmenopausal) who underwent mammography, ultrasonography, and breast MR. We reviewed the mammography for overall breast density of the contralateral normal breast according to the four-point scale of the BI-RADS classification. Ultrasound findings were classified as homogeneous or heterogeneous background echotexture according to the BI-RADS lexicon. We rated background enhancement on a contralateral breast MR into four categories based on subtraction images: absent, mild, moderate, and marked. All imaging findings were interpreted independently by two readers without knowledge of menstrual status, imaging findings of other modalities.

Results

There were significant differences between the premenopausal and postmenopausal group in distribution of mammographic breast density, ultrasonographic background echotexture, and degree of background enhancement. Regarding the relationship between mammographic density and background enhancement, there was no significant correlation. There was significant relationship between ultrasonographic background echotexture and background enhancement in both premenopausal and postmenopausal groups.

Conclusion

There is a significant correlation between ultrasonographic background echotexture and background enhancement in MR regardless of menopausal status. Interpreting breast MR, or scheduling for breast MR of women showing heterogeneous background echotexture needs more caution.  相似文献   

11.

Purpose

The aim of the study was to clarify the effect of the interval between transcatheter hepatic arterial embolization (TAE) with Lipiodol plus gelatin sponge particles and radiofrequency (RF) ablation on the extent of ablation.

Materials and methods

Eight healthy swine were divided into four groups: RF ablation (ablation only), RF ablation immediately after TAE (immediate ablation), RF ablation 3 days after TAE (3-day ablation), and RF ablation 6 days after TAE (6-day ablation). Five ablated lesions were created in each swine (10 per group). A 2-cm expandable LeVeen needle electrode was used for RF ablation. Ablated lesions are composed of an outer reddish zone and an inner whitish zone.

Results

The average longest length of the major, intermediate, and minor axes and the volume in the immediate ablation, 3-day ablation, and 6-day ablation groups were significant longer and greater (1.52 and 1.52, 1.46 and 1.50, and 1.37 and 1.35 times greater in the red zone and the whitish area, respectively) than those in the ablation-only group (P < 0.05/3). Accumulation of Lipiodol was still noted in the hepatic sinusoids in the 3-day and 6-day ablation groups.

Conclusion

RF ablation delayed to 6 days following TAE produced larger ablation volumes than did RF ablation alone.  相似文献   

12.

Purpose

To compare the apparent diffusion coefficient (ADC) values of malignant liver lesions on diffusion-weighted MRI (DWI) before and after successful radiofrequency ablation (RF ablation).

Materials and methods

Thirty-two patients with 43 malignant liver lesions (23/20: metastases/hepatocellular carcinomas (HCC)) underwent liver MRI (3.0 T) before (<1 month) and after RF ablation (at 1, 3 and 6 months) using T2-, gadolinium-enhanced T1- and DWI-weighted MR sequences. Jointly, two radiologists prospectively measured ADCs for each lesion by means of two different regions of interest (ROIs), first including the whole lesion and secondly the area with the visibly most restricted diffusion (MRDA) on ADC map. Changes of ADCs were evaluated with ANOVA and Dunnett tests.

Results

Thirty-one patients were successfully treated, while one patient was excluded due to focal recurrence. In metastases (n = 22), the ADC in the whole lesion and in MRDA showed an up-and-down evolution. In HCC (n = 20), the evolution of ADC was more complex, but with significantly higher values (p = 0.013) at 1 and 6 months after RF ablation.

Conclusion

The ADC values of malignant liver lesions successfully treated by RF ablation show a predictable evolution and may help radiologists to monitor tumor response after treatment.  相似文献   

13.

Purpose

We retrospectively evaluated whether combined use of chemoembolization expands ablative zone sizes created by radiofrequency (RF) ablation in patients with small hepatocellular carcinomas (HCCs).

Materials and methods

Fifty-seven patients treated with single RF ablation for solitary HCC measuring ??2?cm were assessed. RF ablation alone was done in nine patients and in 48 patients following chemoembolization, with an interval of 0?days in 6, 1?C14?days in 27, 15?C28?days in 6, and ??4?weeks in 9. Ablative zone sizes, disappearance of tumor enhancement, and creation of sufficient ablative margins (>5?mm) were evaluated on contrast-enhanced computed tomography (CT) images.

Results

Both mean long-axis (4.2?C4.7 vs. 3.6?±?0.4?cm, p?p?p?Conclusion Ablative zones created by RF ablation with chemoembolization become larger than RF ablation alone, leading to secure ablative margins.  相似文献   

14.

Purpose

To determine the role of diffusion weighted MR imaging and apparent diffusion coefficient (ADC) in chest wall masses.

Materials and methods

This study included 62 patients with chest wall masses. They underwent routine MR imaging and diffusion MR weighted imaging on a 1.5 T MR unit (Symphony-Siemens). Diffusion MR imaging was done with diffusion factor b value of 0, 500, and 1000 s/mm2. The apparent diffusion coefficient (ADC) map was reconstructed. The signal intensity was visually assessed on ADC maps and ADC value was measured in chest wall lesions. The mean ADC values correlated with histo-pathological results.

Results

Adequate ADC maps were obtained in 62 patients. The mean ADC values of chest wall lesions were 1.76 ± 0.08 × 10−3 mm2/s in inflammatory lesion, 3.21 ± 0.05 × 10−3 mm2/s in the cystic lesions, 1.67 ± 0.03 × 10−3 mm2/s in neurofibroma, 2.12 ± 0.07 × 10−3 in haemangioma, and 0.89 ± 0.06 × 10−3 mm2/s in malignant tumors. The mean ADC value of the malignant tumor was significantly different from that of benign chest wall tumors (P < 0.001).

Conclusion

Diffusion weighted MR imaging is a new imaging modality for differentiation malignant from benign chest wall masses. In addition, it has a role in characterization of different malignant and benign tumors.  相似文献   

15.

Objective

The purpose of this study was to assess the technical feasibility and local efficacy of biplane fluoroscopy-guided percutaneous radiofrequency (RF) ablation combined with transcatheter arterial chemoembolisation (TACE) for hepatocellular carcinoma (HCC).

Method

Our retrospective study was approved by the institutional review board and informed consent was waived. 18 patients with 19 HCCs (mean 2.5 cm diameter; range 2–4.2 cm) were treated with percutaneous RF ablation combined with TACE. After segmental TACE, 18 (95%) of 19 HCCs were visible on fluoroscopy. Shortly (median 2 days; range 1–4 days) after TACE, percutaneous RF ablation was performed under real-time biplane fluoroscopic guidance. We evaluated major complications, rate of technical success at immediate post-RF ablation CT images and local tumour progression at follow-up CT images.

Results

Major complication was not observed in any patients. Technical success was achieved for all 18 visible HCCs. During the follow-up period (median 20 months; range 5–30 months), no local tumour progression was found.

Conclusion

Biplane fluoroscopy-guided RF ablation combined with TACE is technically feasible and effective for treatment of HCC.Percutaneous radiofrequency (RF) ablation has been widely implemented in the management of hepatocellular carcinoma (HCC) with promising results. Although its local efficacy for small tumours (i.e. <2 cm) is similar to surgical outcomes [1], results for medium-sized and large tumours are less robust. Thus, multimodal treatments such as combined percutaneous RF ablation with transarterial chemoembolisation (TACE) have been explored for medium or large HCCs in order to enhance the therapeutic effect. In a recent study, RF ablation combined with TACE was similar to surgical resection in patients with early-stage disease [2].Percutaneous RF ablation shortly following TACE has been usually performed under guidance of either ultrasonography or CT/CT fluoroscopy. Since intratumoural retention of radio-opaque iodised oil induced by TACE conveniently provides radiographic contrast to the index lesion, biplane fluoroscopy (anterior posterior and lateral projections) can be used as an alternative guiding modality for RF ablation combined with TACE. Easier targeting of dome lesions, often difficult to visualise on ultrasound, through an oblique approach without pleural transgression is one potential advantage of biplane fluoroscopy guidance. Also unlike on ultrasound, microbubble formation during ablation would not obscure the index lesion on biplane fluoroscopy, allowing easier and more spatially accurate application of overlapping ablations that are often needed for larger tumours. However, to our knowledge, there have been no studies investigating the role of biplane fluoroscopy as a guidance modality in this clinical setting. The purpose of our study was to retrospectively assess the technical feasibility and local efficacy of biplane fluoroscopy-guided percutaneous RF ablation combined with TACE for HCC ≥2 cm.  相似文献   

16.

Purpose

To assess clinical efficacy and safety of image-guided percutaneous radiofrequency (RF) ablation of central renal cell carcinoma with adjunctive pyeloperfusion.

Materials and Methods

Patients with central renal tumors who underwent percutaneous RF ablation between 2005 and 2010 were retrospectively evaluated. Thirty patients with 31 central renal tumors underwent 39 RF ablation sessions. Mean tumor diameter was 3.7 cm (range, 2–7 cm). Median distance between tumor and renal pelvis was 5 mm (range, 0–15 mm). Pyeloperfusion was performed in 27 patients (27/30; 90%). Contrast–enhanced CT or MR imaging was performed to evaluate treatment response.

Results

Technical success of RF ablation was achieved in 38/39 (97.4%) ablation sessions. Primary efficacy was 83.9% (26/31) on first follow-up imaging. One (3.2%) case of local tumor progression was detected 6 months after initial ablation. Secondary efficacy was 96.8% (30/31) after repeat RF ablation for residual tumor or local tumor progression. Median follow-up was 88 months (mean 82.6 mo ± 30.7; range, 9–121 mo). Major complications occurred in 5/39 (12.8%) RF ablation sessions. Complications were significantly higher for tumors located within 5 mm of the renal pelvis or 0 mm of a major calyx (28.6% vs 4.0%; P < .05). Overall survival was 96.0% (95% CI, 88.4%–100.0%), and progression-free survival at 5 years was 80.9% (95% CI, 65.8%–95.9%).

Conclusion

Image-guided percutaneous RF ablation combined with pyeloperfusion has satisfactory clinical efficacy in treating central renal tumors. Although clinically effective, RF ablation of central tumors may also be associated with significant major complications.  相似文献   

17.

Purpose

To compare the effectiveness of microwave (MW) ablation with radiofrequency (RF) ablation for treating breast tissue in a nonperfused ex vivo model of healthy bovine udder tissue.

Materials and Methods

MW ablations were performed at power outputs of 25W, 35W, and 45W using a 915-MHz frequency generator and a 2-cm active tip antenna. RF ablations were performed with a bipolar RF system with 2- and 3-cm active tip electrodes. Tissue temperatures were continuously monitored during ablation.

Results

The mean short-axis diameters of the coagulation zones were 1.34 ± 0.14, 1.45 ± 0.13, and 1.74 ± 0.11 cm for MW ablation at outputs of 25W, 35W, and 45W. For RF ablation, the corresponding values were 1.16 ± 0.09 and 1.26 ± 0.14 cm with electrodes having 2- and 3-cm active tips, respectively. The mean coagulation volumes were 2.27 ± 0.65, 2.85 ± 0.72, and 4.45 ± 0.47 cm3 for MW ablation at outputs of 25W, 35W, and 45W and 1.18 ± 0.30 and 2.29 ± 0.55 cm3 got RF ablation with 2- and 3-cm electrodes, respectively. MW ablations at 35W and 45W achieved significantly longer short-axis diameters than RF ablations (P < 0.05). The highest tissue temperature was achieved with MW ablation at 45W (P < 0.05). On histological examination, the extent of the ablation zone in MW ablations was less affected by tissue heterogeneity than that in RF ablations.

Conclusion

MW ablation appears to be advantageous with respect to the volume of ablation and the shape of the margin of necrosis compared with RF ablation in an ex vivo bovine udder.  相似文献   

18.

Objective

To assess the safety and effectiveness of image-guided radiofrequency ablation (RF ablation) in the treatment of chondroblastomas as an alternative to surgery.

Materials and Methods

Twelve patients with histologically proven chondroblastoma at our institution from 2003 to date. We reviewed the indications, recurrences and complications in patients who underwent RF ablation.

Results

Twelve patients were diagnosed with chondroblastoma. Out of these, 8 patients (6 male, 2 female, mean age 17 years) with chondroblastoma (mean size 2.7 cm) underwent RF ablation. Multitine expandable electrodes were used in all patients. The number of probe positions needed varied from 1 to 4 and lesions were ablated at 90 °C for 5 min at each probe position. The tumours were successfully treated and all patients became asymptomatic. There were no recurrences. There were 2 patients with knee complications, 1 with minor asymptomatic infraction of the subchondral bone and a second patient with osteonecrosis/chondrolysis.

Conclusion

Radiofrequency ablation appears to be a safe and effective alternative to surgical treatment with a low risk of recurrence and complications for most chondroblastomas. RF ablation is probably superior to surgery when chondroblastomas are small (less than 2.5 cm) with an intact bony margin with subchondral bone and in areas of difficult surgical access.  相似文献   

19.

Objective

The diagnostic accuracy of MSCT and MRI for evaluation of hepatic focal lesions.

Design

An analytic comparative study.

Setting

Radiology Department, Farwania Hospital.

Subjects

Ninety-five hepatic focal lesions, 61 patients were examined from October 2006 to March 2010. Gold standard was biopsy, radiological and clinical follow up.

Main outcome

The value of CT and MRI in characterizing these lesions was assessed.

Results

The mean sensitivity of MRI was (72.5%) and CT (72.6%) in the detection of overall hepatic focal lesions. However, the positive predictive value for MRI was 96.1% and for CT was 91.5%. False negative results were the problem of MRI and CT in lesions ?2 cm (33.8% and 30.5%, respectively). About lesion characterization, MRI was relatively highly specific for diagnosis of HCC (87.5%), hemangioma (91.2%) and metastases (87.8%).

Conclusion

An analytic comparative study.  相似文献   

20.

Purpose

To demonstrate cellular selectivity toward hepatoma cells and compare the efficiency of gene delivery of a novel nonviral vector of iopamidol, protamine, and ethiodized oil reagents (VIPER).

Materials and Methods

Rat hepatocellular carcinoma (HCC) cells were transfected in triplicate under varying conditions by using firefly luciferase as a reporter gene. Conditions included variations of a protamine:DNA (P:D) complex (20:1, 50:1, 100:1, 200:1 mass ratios), iopamidol (0%, 10%, 33%), and ethiodized oil (0%, 1%, 2%, 4%, 8%, and 16%). The conditions affording efficient gene transfer and ease of translation to in vivo studies were selected for cell line comparison (HCC cells vs hepatocytes). Adenoviral transduction was compared with nonviral vector transfection.

Results

At low concentrations, ethiodized oil increased transfection efficiency regardless of P:D mass ratio. However, high concentrations resulted in significant attenuation. Unexpectedly, the addition of iopamidol to P:D complexes markedly improved transfection efficiency. When using an optimal P:D, iopamidol, and ethiodized oil solution, DNA transfection of normal liver and tumor cells showed significant selectivity for tumor cells. In the context of hepatoma cells, transfection efficiency with the nonviral vector was better than 104 pfu adenovirus.

Conclusions

The development and characterization of the VIPER system provides a possible alternative to viral gene therapy of HCC.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号